Vaxart to Present Clinical Data From its Norovirus Phase 1b Study at Three Global Healthcare Conferences in October 2019

NEXT STORY
PDS Biotechnology Prioritizes Development of PDS0101 in Advanced Cancers Following Promising Phase 1 Clinical Outcome Data
PREV STORY
Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Catalyst Psychiatry Now Offering Mental Health Technology for Patients with Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Corvallis

author_avatar
NASDAQ Market News

Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States

author_avatar
NASDAQ Market News

AIT Therapeutics Appoints Yoori Lee to its Board of Directors

Seasoned veteran with decades of strategic, scientific, clinical and leadership experience NEW YORK, Jan. ...

author_avatar
NASDAQ Market News